<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" xml:lang="ko" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJORL</journal-id>
<journal-title-group>
<journal-title>Korean Journal of Otorhinolaryngology-Head and Neck Surgery</journal-title><abbrev-journal-title>Korean J Otorhinolaryngol-Head Neck Surg</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">2092-5859</issn>
<issn pub-type="epub">2092-6529</issn>
<publisher>
<publisher-name>Korean Society of Otolaryngology-Head and Neck Surgery</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3342/kjorl-hns.2022.00451</article-id>
<article-id pub-id-type="publisher-id">kjorl-hns-2022-00451</article-id>
<article-categories>
<subj-group>
<subject>Case Report</subject></subj-group></article-categories>
<title-group>
<article-title>단기 국소 항생제 치료를 통해 호전된 비강 내 방선균증: 증례 보고 및 문헌 고찰</article-title>
<trans-title-group>
<trans-title xml:lang="en">Short-Term Topical Antibiotic Treatment in Nasal Cavity Actinomycosis: Case Report and Literature Review</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Mun</surname><given-names>Young Min</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>문</surname><given-names>영민</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjorl-hns-2022-00451"/>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Im</surname><given-names>Sang Kwon</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>임</surname><given-names>상권</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjorl-hns-2022-00451"/>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Gyu Man</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>이</surname><given-names>규만</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjorl-hns-2022-00451"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6398-1297</contrib-id>
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Jung</surname><given-names>Su Young</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>정</surname><given-names>수영</given-names></name>
</name-alternatives>
<xref ref-type="corresp" rid="c1-kjorl-hns-2022-00451"/>
<xref ref-type="aff" rid="af1-kjorl-hns-2022-00451"/>
</contrib>
<aff-alternatives id="af1-kjorl-hns-2022-00451">
<aff xml:lang="en">Department of Otorhinolaryngology, Myongji Hospital, Hanyang University College of Medicine, Goyang, <country>Korea</country></aff>
<aff xml:lang="ko">한양대학교 의과대학 명지병원 이비인후과학교실</aff>
</aff-alternatives>
</contrib-group>
<author-notes>
<corresp id="c1-kjorl-hns-2022-00451">Address for correspondence Su Young Jung, MD, PhD Department of Otorhinolaryngology, Myongji Hospital, Hanyang University College of Medicine, 55 Hwasu-ro 14beon-gil, Deokyang-gu, Goyang 10475, Korea Tel +82-31-810-6359 Fax +82-31-969-0500 E-mail <email>monkiwh35@hanmail.net</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2022</year></pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>9</month>
<year>2022</year></pub-date>
<volume>65</volume>
<issue>9</issue>
<fpage>547</fpage>
<lpage>552</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>05</month>
<year>2022</year></date>
<date date-type="rev-recd">
<day>22</day>
<month>06</month>
<year>2022</year></date>
<date date-type="accepted">
<day>22</day>
<month>06</month>
<year>2022</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000a9; 2022  Korean Society of Otorhinolaryngology-Head and Neck Surgery</copyright-statement>
<copyright-year>2022</copyright-year>
<license>
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<trans-abstract xml:lang="en"><p>Actinomycosis is a rare acute-to-chronic bacterial infection caused by <italic>Actinomyces</italic>. A 7-year-old healthy girl presented with left-sided nasal obstruction and purulent discharge. She had no special medical or trauma history, and the symptoms developed gradually after severe vomiting one month prior to the visit. Nasal endoscopy revealed white-black-colored cheesy material that appeared as a foreign body or fungal material in the left nasal cavity. The lesion was completely removed endoscopically under local anesthesia. The patient was prescribed only a topical antibiotic ointment without any additional systemic antibiotics. She was diagnosed with actinomycosis based on histopathological examination after a few days. There was no recurrence at six months post-procedure. The common treatment for actinomycosis is surgical removal and a systemic antibiotic therapy. However, this case was successful with complete surgical removal and only a short-term topical antibiotic ointment therapy. Therefore, the treatment for actinomycosis should differ based on clinical characteristics and the patient&#x02019;s condition.</p></trans-abstract>
<kwd-group xml:lang="en">
<kwd>Actinomycosis</kwd> 
<kwd>Nasal cavity</kwd>
<kwd>Surgical excision</kwd>
<kwd>Topical antibiotics</kwd>
</kwd-group>
</article-meta></front>
<body>
<sec>
<title>Introduction</title>
<p>Actinomycosis is a rare human disease caused by <italic>Actinomyces</italic>. <italic>Actinomyces</italic> belong to the normal flora of the oral cavity, gastrointestinal tract, and urogenital tract. In general, due to its weak infectivity in the human body, it usually causes infection through damaged mucosa in patients undergoing long-term steroid treatment, or patients with diabetes or an immunodeficiency disease &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>-<xref ref-type="bibr" rid="b5-kjorl-hns-2022-00451">5</xref>&#x0005d;. Although the most common clinical form of actinomycosis is cervicofacial, involvement of the nose, such as the nasal cavity, is extremely rare &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>-<xref ref-type="bibr" rid="b13-kjorl-hns-2022-00451">13</xref>&#x0005d;.</p>
<p>We report a rare case of nasal actinomycosis caused by residual vomiting in the nasal cavity in of a healthy child with no special medical history. The purpose of the study was explained to patient and her guardians, with all providing written informed consent for use of patient&#x02019;s medical informations. The study protocol was approved by the Institutional Review Board of our hospital.</p>
</sec>
<sec>
<title>Case</title>
<p>A 7-year-old healthy girl presented to our hospital with one month of nasal obstruction and mucopurulent nasal discharge. The patient had no medical or dental problems and had no history of surgery or trauma. The patient&#x02019;s guardian said that she had severely vomited one month prior, and at that time, part of the vomit had been regurgitated into the nasal passages and was discharged out of the body through the nostrils. The guardian recalled that, the symptoms seemed to have occurred a few days after the vomiting event. About two weeks after the onset of symptoms, she visited a local pediatric clinic, was diagnosed with a common cold, and took the prescribed medication for one week, but the symptoms persisted. She then visited our outpatients department (OPD).</p>
<p>Nasal endoscopy confirmed a dark black substance in the form of a mass that partially obstructed the space in the left nasal cavity (<xref rid="f1-kjorl-hns-2022-00451" ref-type="fig">Fig. 1A</xref>). On paranasal sinus CT, a mass-like material with a clear boundary that did not invade other tissues was observed in the left nasal cavity. The lesion was round and boundary of calcified material appeared to have been formed around the lesion (<xref rid="f2-kjorl-hns-2022-00451" ref-type="fig">Fig. 2</xref>). The lesion was removed endoscopically under local anesthesia in the OPD. No abnormal findings on the mucosa were observed after removal (<xref rid="f1-kjorl-hns-2022-00451" ref-type="fig">Fig. 1B</xref>). Additional mucosal biopsies were not performed to check for infiltration into other tissues because of the patient&#x02019;s inability to cooperate. Therefore, only the specimens that were successfully removed were biopsied. At the time of removal, the patient was considered to have a simple foreign body, and no additional systemic antibiotic treatment was administered. A mupirocin ointment was prescribed for the patient to self-apply to the lesion site for one week. Owing to the patient&#x02019;s personal circumstances (quarantine due to close contact with COVID-19), follow-up was performed after two weeks. At that time, the previous biopsy results had confirmed actinomycosis (<xref rid="f1-kjorl-hns-2022-00451" ref-type="fig">Fig. 1C</xref>). No recurrence or other specific findings were observed on nasal endoscopy. Therefore, regular follow-up was performed on an OPD basis without additional prescription of any drugs. At six months post-procedure, normal nasal mucosa was observed on nasal endoscopy without relapse or worsening.</p>
</sec>
<sec>
<title>Discussion</title>
<p><italic>Actinomyces</italic> are normal flora in human mucosal tissue, such as the oral cavity and gastrointestinal and genital organs &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>-<xref ref-type="bibr" rid="b14-kjorl-hns-2022-00451">14</xref>&#x0005d;. However, sometimes it can become pathogenic. This is called actinomycosis and usually occurs following the destruction of normal mucosal tissue in the presence of other bacteria, especially in anaerobic environments, which enables the growth of these colonies. Therefore, most cases occur after surgical procedures, such as abdominal surgery, intrauterine device insertion, or dental extractions. In addition, systemic diseases, such as diabetes and immunosuppression, are known risk factors for actinomycosis &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>-<xref ref-type="bibr" rid="b5-kjorl-hns-2022-00451">5</xref>&#x0005d;. However, in our case, the patient had no risk factors other than severe vomiting prior to the diagnosis. Therefore, in this case, it seems that <italic>Actinomyces</italic>, which exists as a normal strain in the gastrointestinal tract, moved into the nasal cavity due to nasal reflux of gastric contents through vomiting and formed a lesion. Although it has already been found in various studies that vomit or gastric acid reflux into the nasal cavity can act as a causative agent for inflammatory diseases, such as chronic rhinosinusitis (CRS), this is the first case in which intranasal actinomycosis is assumed to be caused by vomiting &#x0005b;<xref ref-type="bibr" rid="b15-kjorl-hns-2022-00451">15</xref>&#x0005d;.</p>
<p>Actinomycosis can be classified: cervicofacial, thoracic, abdominopelvic, central nervous system, musculoskeletal, or disseminated. Approximately 60% occur in the cervicofacial region, most of which are found in the mandible, cheek, and chin &#x0005b;<xref ref-type="bibr" rid="b14-kjorl-hns-2022-00451">14</xref>&#x0005d;. Rhinologic actinomycosis is extremely rare, and has been mostly reported in the sinuses. According to our literature review, besides our case, there have only been 12 cases reported of actinomycosis occurring in the nasal cavity, such as the nasal septum, nasal floor, or the turbinates (<xref rid="t1-kjorl-hns-2022-00451" ref-type="table">Table 1</xref>) &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>-<xref ref-type="bibr" rid="b6-kjorl-hns-2022-00451">6</xref>,<xref ref-type="bibr" rid="b8-kjorl-hns-2022-00451">8</xref>-<xref ref-type="bibr" rid="b13-kjorl-hns-2022-00451">13</xref>&#x0005d;. <italic>Actinomyces</italic> is an anaerobic bacterium. Therefore, for this organism to act as a pathogen in the human body, it is necessary that the surrounding environment be anaerobic. Since the nasal cavity is continuously exposed to airflow, this anaerobic environment is not well-maintained, so the incidence is considered very rare &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>-<xref ref-type="bibr" rid="b13-kjorl-hns-2022-00451">13</xref>&#x0005d;.</p>
<p>Actinomycosis can also be classified into acute, subacute, or chronic, according to the rate of disease progression. In most cases, it has a chronic course that progresses to lesions, such as granulation tissue or abscess formation, but in some reports, it can lead to acute progression and even death &#x0005b;<xref ref-type="bibr" rid="b4-kjorl-hns-2022-00451">4</xref>-<xref ref-type="bibr" rid="b10-kjorl-hns-2022-00451">10</xref>&#x0005d;. Given the non-specific symptoms associated with rhinologic actinomycosis, such as nasal obstruction, foul odor, epistaxis, and mucopurulent rhinorrhea, it is difficult to differentiate it from CRS often causing a delay in diagnosis &#x0005b;<xref ref-type="bibr" rid="b15-kjorl-hns-2022-00451">15</xref>&#x0005d;. However, in this case, the patient had no prior rhinitis-related symptoms, and the lesion was removed before becoming chronic since the symptom presentation was relatively clear despite the patient&#x02019;s age and treatment was provided early. For this reason, proper removal of the lesion was performed before the bacterial tissue had penetrated the mucosa, and the lesion could heal without the need to remove additional mucosa.</p>
<p>Unlike most bacterial infectious diseases, which are diagnosed based on positive culture results of pathogenic bacteria, diagnosing actinomycosis may be difficult as a result of the low isolation rate of bacteria. In this case, culture result were negative. Therefore, actinomycosis should be diagnosed based on clinical examinations, histopathological findings, and the presensce of sulfur granules &#x0005b;<xref ref-type="bibr" rid="b7-kjorl-hns-2022-00451">7</xref>,<xref ref-type="bibr" rid="b14-kjorl-hns-2022-00451">14</xref>&#x0005d;. If sulfur granules are observed in the exudates of the lesion, actinomycosis may be suspected. However, the probability of diagnosing sulfur granules through histopathological examination is approximately 30% &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>,<xref ref-type="bibr" rid="b3-kjorl-hns-2022-00451">3</xref>,<xref ref-type="bibr" rid="b7-kjorl-hns-2022-00451">7</xref>&#x0005d;. While they can also be found in other diseases, such as noncardiosis, the presence of filamentous gram-positive rods and sulfur granules on histopathological examination may be considered a characteristic finding of actinomycosis. These findings were also confirmed by histopathological examination in our case. The eosinophilic material observed at the periphery of the mass was composed of filamentous or granular bacterial colonies with long, slender, straight, or wrinkled black features, which is suggestive of <italic>Actinomyces</italic> (<xref rid="f1-kjorl-hns-2022-00451" ref-type="fig">Fig. 1C</xref>). CT scans can be helpful to determining the exact location and extent of involvement, as well as identifying any bony destruction, although there is no uniform characteristic that can absolutely confirm a diagnosis &#x0005b;<xref ref-type="bibr" rid="b10-kjorl-hns-2022-00451">10</xref>&#x0005d;.</p>
<p>Actinomycosis treatment involves the administration of penicillin-based antibiotics and surgical removal of the lesion, but clinically, a combination of medical and surgical treatment is recommended &#x0005b;<xref ref-type="bibr" rid="b7-kjorl-hns-2022-00451">7</xref>,<xref ref-type="bibr" rid="b14-kjorl-hns-2022-00451">14</xref>&#x0005d;. However, there is no established treatment protocol for actinomycosis owing to its rarity. Surgical debridement is required to remove the source of the infection or infected tissue and drain the abscess. Long-term antibiotic therapy is recommended following surgery. Although high-dose penicillin is the drug of choice, multiple antibiotics have been used and can be tailored to the severity, location, and extension of the disease and health status of the patient. In patients with penicillin allergies, tetracycline, clindamycin and erythromycin may be used &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>-<xref ref-type="bibr" rid="b6-kjorl-hns-2022-00451">6</xref>&#x0005d;. For this case, endoscopic surgical removal was performed at the OPD, and mupirocin topical ointment was prescribed for one week post-procedure. No additional systemic antibiotics were administered. In other words, the titer of the antibiotics prescribed to our patients was very low compared to the penicillin-based systemic antibiotic protocol that is generally prescribed for actinomycosis &#x0005b;<xref ref-type="bibr" rid="b4-kjorl-hns-2022-00451">4</xref>&#x0005d;. However, at the regular follow-ups at two weeks and six months after surgery, no recurrence was observed, and the symptoms had disappeared. Therefore, surgery and short-term topical antibiotic treatment for this patient were considered effective. This is presumably because the pathogenic potency was not strong, as the lesion was caused by accidental colonization of <italic>Actinomyces</italic> by the reflux of vomit in the absence of damage to the nasal mucosal tissue. In addition, the patient&#x02019;s lesion was removed relatively early, and thus infiltration into the surrounding tissues did not progress.</p>
<p>In conclusion, although nasal actinomycosis is rare, it should be considered for the differential diagnosis of a mass-like lesion that looks like a foreign body on endoscope or a calcified nasal cavity mass on CT. Treatment for nasal actinomycosis has not yet been established, but in the case of a relatively mild disease, as in our case, tailored therapy may be applied that takes into account the patient&#x02019;s condition and the severity of the lesion.</p>
</sec>
</body>
<back>
<ack><p>The purpose of the study was explained to patient and her guardians, with all providing written informed consent for use of patient’s medical informations. The study protocol was approved by the Institutional Review Board of our hospital.</p></ack>
<fn-group>
<fn fn-type="participating-researchers"><p><bold>Author Contribution</bold></p>
<p>Conceptualization: Su Young Jung, Young Min Mun. Data curation: Young Min Mun, Sang Kwon Im. Formal analysis: Young Min Mun. Resources: Young Min Mun, Gyu Man Lee. Supervision: Su Young Jung. Writing—original draft: Young Min Mun, Su Young Jung. Writing—review &amp; editing: Su Young Jung.</p></fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-kjorl-hns-2022-00451">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lombo</surname><given-names>C</given-names></name>
<name><surname>Matos</surname><given-names>C</given-names></name>
<name><surname>Fernandes</surname><given-names>F</given-names></name>
</person-group>
<article-title>Actinomycosis of the nasal septum: A rare entity</article-title>
<source>Cureus</source>
<year>2021</year>
<volume>13</volume>
<issue>11</issue>
<fpage>e19475</fpage>
</element-citation></ref>
<ref id="b2-kjorl-hns-2022-00451">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kingdom</surname><given-names>TT</given-names></name>
<name><surname>Tami</surname><given-names>TA</given-names></name>
</person-group>
<article-title>Actinomycosis of the nasal septum in a patient i nfected with the hu man im mu nodef iciency vi r us</article-title>
<source>Otolaryngol Head Neck Surg</source>
<year>1994</year>
<volume>111</volume>
<issue>1</issue>
<fpage>130</fpage>
<lpage>3</lpage>
</element-citation></ref>
<ref id="b3-kjorl-hns-2022-00451">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JH</given-names></name>
<name><surname>Jeong</surname><given-names>JY</given-names></name>
<name><surname>Kim</surname><given-names>JS</given-names></name>
<name><surname>Hoe</surname><given-names>SJ</given-names></name>
</person-group>
<article-title>A case of chronic noninvasive actinomycosis in the nasal cavity</article-title>
<source>Korean J Otorhinolaryngol-Head Neck Surg</source>
<year>2017</year>
<volume>60</volume>
<issue>3</issue>
<fpage>144</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b4-kjorl-hns-2022-00451">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sakuma</surname><given-names>Y</given-names></name>
<name><surname>Yamashita</surname><given-names>Y</given-names></name>
<name><surname>Shiono</surname><given-names>O</given-names></name>
<name><surname>Oridate</surname><given-names>N</given-names></name>
</person-group>
<article-title>Actinomycosis arising from the nasal cavity, with rare fatal progression</article-title>
<source>BMJ Case Rep</source>
<year>2016</year>
<volume>2016</volume>
<fpage>bcr2015213747</fpage>
</element-citation></ref>
<ref id="b5-kjorl-hns-2022-00451">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ozcan</surname><given-names>C</given-names></name>
<name><surname>Talas</surname><given-names>D</given-names></name>
<name><surname>G&#x000f6;r&#x000fc;r</surname><given-names>K</given-names></name>
<name><surname>Aydin</surname><given-names>O</given-names></name>
<name><surname>Yildiz</surname><given-names>A</given-names></name>
</person-group>
<article-title>Actinomycosis of the middle turbinate: An unusual cause of nasal obstruction</article-title>
<source>Eur Arch Otorhinolaryngol</source>
<year>2005</year>
<volume>262</volume>
<issue>5</issue>
<fpage>412</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b6-kjorl-hns-2022-00451">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>KS</given-names></name>
<name><surname>Lee</surname><given-names>DH</given-names></name>
<name><surname>Lim</surname><given-names>SC</given-names></name>
</person-group>
<article-title>Actinomycosis of the nasal cavity</article-title>
<source>Braz J Otorhinolaryngol</source>
<comment>In press 2021</comment>
</element-citation></ref>
<ref id="b7-kjorl-hns-2022-00451">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Valour</surname><given-names>F</given-names></name>
<name><surname>S&#x000e9;n&#x000e9;chal</surname><given-names>A</given-names></name>
<name><surname>Dupieux</surname><given-names>C</given-names></name>
<name><surname>Karsenty</surname><given-names>J</given-names></name>
<name><surname>Lustig</surname><given-names>S</given-names></name>
<name><surname>Breton</surname><given-names>P</given-names></name>
<etal/>
</person-group>
<article-title>Actinomycosis: Etiology, clinical features, diagnosis, treatment, and management</article-title>
<source>Infect Drug Resist</source>
<year>2014</year>
<volume>7</volume>
<fpage>183</fpage>
<lpage>97</lpage>
</element-citation></ref>
<ref id="b8-kjorl-hns-2022-00451">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kamogashira</surname><given-names>T</given-names></name>
<name><surname>Matsumoto</surname><given-names>N</given-names></name>
<name><surname>Numakura</surname><given-names>S</given-names></name>
<name><surname>Kikuchi</surname><given-names>Y</given-names></name>
<name><surname>Ito</surname><given-names>K</given-names></name>
</person-group>
<article-title>Rhinolithiasis caused by actinomyces with a foreign body</article-title>
<source>IDCases</source>
<year>2020</year>
<volume>19</volume>
<fpage>e00718</fpage>
</element-citation></ref>
<ref id="b9-kjorl-hns-2022-00451">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>DH</given-names></name>
<name><surname>Yoon</surname><given-names>TM</given-names></name>
<name><surname>Lee</surname><given-names>JK</given-names></name>
<name><surname>Lim</surname><given-names>SC</given-names></name>
</person-group>
<article-title>Nasal septum actinomycosis mimicking mucocele</article-title>
<source>J Craniofac Surg</source>
<year>2020</year>
<volume>31</volume>
<issue>2</issue>
<fpage>e147</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b10-kjorl-hns-2022-00451">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SD</given-names></name>
<name><surname>Kim</surname><given-names>DS</given-names></name>
<name><surname>Choi</surname><given-names>KU</given-names></name>
<name><surname>Cho</surname><given-names>KS</given-names></name>
</person-group>
<article-title>Nasal cavity actinomycosis mimicking rhinolith</article-title>
<source>J Craniofac Surg</source>
<year>2018</year>
<volume>29</volume>
<issue>3</issue>
<fpage>e255</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b11-kjorl-hns-2022-00451">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JS</given-names></name>
<name><surname>Noh</surname><given-names>SJ</given-names></name>
<name><surname>Ryu</surname><given-names>SH</given-names></name>
</person-group>
<article-title>Osteoma with actinomycosis in a nasal cavity: A case report</article-title>
<source>Medicine (Baltimore)</source>
<year>2017</year>
<volume>96</volume>
<issue>51</issue>
<fpage>e9376</fpage>
</element-citation></ref>
<ref id="b12-kjorl-hns-2022-00451">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Batzakakis</surname><given-names>D</given-names></name>
<name><surname>Karkos</surname><given-names>PD</given-names></name>
<name><surname>Papouliakos</surname><given-names>S</given-names></name>
<name><surname>Leong</surname><given-names>SC</given-names></name>
<name><surname>Bardanis</surname><given-names>I</given-names></name>
</person-group>
<article-title>Nasal actinomycosis mimicking a foreign body</article-title>
<source>Ear Nose Throat J</source>
<year>2013</year>
<volume>92</volume>
<issue>7</issue>
<fpage>E14</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b13-kjorl-hns-2022-00451">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zalagh</surname><given-names>M</given-names></name>
<name><surname>Akhaddar</surname><given-names>A</given-names></name>
<name><surname>Benariba</surname><given-names>F</given-names></name>
</person-group>
<article-title>Chronic rhinorrhea revealing an actinomycotic rhinolithiasis with ectopic tooth</article-title>
<source>Int J Oral Maxillofac Surg</source>
<year>2012</year>
<volume>41</volume>
<issue>3</issue>
<fpage>297</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b14-kjorl-hns-2022-00451">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vorasubi n</surname><given-names>N</given-names></name>
<name><surname>Wu</surname><given-names>AW</given-names></name>
<name><surname>Day</surname><given-names>C</given-names></name>
<name><surname>Su h J</surname><given-names>D</given-names></name>
</person-group>
<article-title>I nvasive si nonasal actinomycosis: Case report and literature review</article-title>
<source>Laryngoscope</source>
<year>2013</year>
<volume>123</volume>
<issue>2</issue>
<fpage>334</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b15-kjorl-hns-2022-00451">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SY</given-names></name>
<name><surname>Park</surname><given-names>B</given-names></name>
<name><surname>Lim</surname><given-names>H</given-names></name>
<name><surname>Kim</surname><given-names>M</given-names></name>
<name><surname>Kong</surname><given-names>IG</given-names></name>
<name><surname>Choi</surname><given-names>HG</given-names></name>
</person-group>
<article-title>Gastroesophageal ref lux disease increases the risk of chronic rhinosinusitis: A nested case-control study using a national sample cohort</article-title>
<source>Int Forum Allergy Rhinol</source>
<year>2019</year>
<volume>9</volume>
<issue>4</issue>
<fpage>357</fpage>
<lpage>62</lpage>
</element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Table</title>
<fig id="f1-kjorl-hns-2022-00451" position="float">
<label>Fig. 1.</label><caption><p>Nasal endoscopic and histopathologic findings. A: Endoscopic findings of the left nasal cavity revealed a yellow-whitish material adhering to the left nasal septum and a dark brown-colored mass adjacent to the inferior turbinate. B: Relatively normal nasal mucosal findings after endoscopic removal of the mass lesion. C: The eosinophilic material seen at the periphery of the mass is composed of filamentous or granular bacterial colonies without fungal spores. The filamentous structures are showing long, slender, straight or wrinkled black features suggestive of <italic>Actinomyces</italic>.</p></caption>
<graphic xlink:href="kjorl-hns-2022-00451f1.tif"/></fig>
<fig id="f2-kjorl-hns-2022-00451" position="float">
<label>Fig. 2.</label><caption><p>Preoperative paranasal sinus CT scan findings. Coronal (A) and axial (B) views of the left nasal cavity showing a round calcified peripheral mass (arrow) in the left nasal cavity. No bone destruction or invasion was observed.</p></caption>
<graphic xlink:href="kjorl-hns-2022-00451f2.tif"/></fig>
<table-wrap id="t1-kjorl-hns-2022-00451" position="float">
<label>Table 1.</label>
<caption><p>Literature review of nasal cavity actinomycosis</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="center" valign="middle" rowspan="2">Authors</th>
<th align="center" valign="middle" rowspan="2">Age (sex)</th>
<th align="center" valign="middle" colspan="2">Predisposing factors<hr/></th>
<th align="center" valign="middle" rowspan="2">Symptoms</th>
<th align="center" valign="middle" rowspan="2">Duration (mo)</th>
<th align="center" valign="middle" rowspan="2">Location (direction)</th>
<th align="center" valign="middle" rowspan="2">Pre op Dx.</th>
<th align="center" valign="middle" colspan="4">Treatment options<hr/></th>
<th align="center" valign="middle" rowspan="2">F/U (mo)</th>
<th align="center" valign="middle" rowspan="2">Recur</th>
</tr><tr>
<th align="center" valign="middle">Underlying diseases</th>
<th align="center" valign="middle">Etc.</th>
<th align="center" valign="middle">Surgery</th>
<th align="center" valign="middle">PO anti</th>
<th align="center" valign="middle">IV anti</th>
<th align="center" valign="middle">Etc</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Lombo, et al. [<xref ref-type="bibr" rid="b1-kjorl-hns-2022-00451">1</xref>]</td>
<td valign="top" align="center">84 (F)</td>
<td valign="top" align="left">Breast ca c bone meta (immunotherapy), HTN, DM, dyslipidemia</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Sleep apnea, bilateral permanent nasal obstruction, mucous rhinorrhea</td>
<td valign="top" align="center">3</td>
<td valign="top" align="left">Septum (both)</td>
<td valign="top" align="left">Metastasis or other malignancy</td>
<td valign="top" align="left">Rouge-Denker approach</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Amoxicillin (3 mo)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Kingdom, et al. [<xref ref-type="bibr" rid="b2-kjorl-hns-2022-00451">2</xref>]</td>
<td valign="top" align="center">51 (M)</td>
<td valign="top" align="left">Intravenous drug abuser, infected with HIV</td>
<td valign="top" align="left">Facial trauma</td>
<td valign="top" align="left">Purulent nasal discharge</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">Septum (left)</td>
<td valign="top" align="left">Stapylococcal abscess</td>
<td valign="top" align="left">Submucosal resection with debulking of the mass</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Dicloxacillin (28 days)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">?</td>
<td valign="top" align="left">?</td>
</tr>
<tr>
<td valign="top" align="left">Lee, et al. [<xref ref-type="bibr" rid="b3-kjorl-hns-2022-00451">3</xref>]</td>
<td valign="top" align="center">49 (F)</td>
<td valign="top" align="left">DM</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Epistaxis, foul odor</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">Nasal cavity (right)</td>
<td valign="top" align="left">Actinomycosis</td>
<td valign="top" align="left">Endoscopic endonasal surgery</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Sultamicillin toslyate hydrate (1 week)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">26</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Sakuma, et al. [<xref ref-type="bibr" rid="b4-kjorl-hns-2022-00451">4</xref>]</td>
<td valign="top" align="center">54 (M)</td>
<td valign="top" align="left">DM, hepatitis C virus infection</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Nasal obstruction, swelling, sharp nasal pain, purulent nasal discharge</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">Middle and inferior turbinate (left)</td>
<td valign="top" align="left">R/o malignancy</td>
<td valign="top" align="left">Surgery</td>
<td valign="top" align="left">Ampicillin/sulbactam (6 days)</td>
<td valign="top" align="left">Amoxicillin (4 months)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">4</td>
<td valign="top" align="left">Expired d/t recurred local infection 7 mo post-op</td>
</tr>
<tr>
<td valign="top" align="left">Ozcan, et al. [<xref ref-type="bibr" rid="b5-kjorl-hns-2022-00451">5</xref>]</td>
<td valign="top" align="center">75 (F)</td>
<td valign="top" align="left">Coronary heart disease</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Nasal obstruction, cheek swelling</td>
<td valign="top" align="center">12</td>
<td valign="top" align="left">Nasal cavity (right)</td>
<td valign="top" align="left">R/o benign neoplasm</td>
<td valign="top" align="left">Endoscopic endonasal surgery + Caldwell-Luc approach</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Penicillin v (3 months)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">3</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Park, et al. [<xref ref-type="bibr" rid="b6-kjorl-hns-2022-00451">6</xref>]</td>
<td valign="top" align="center">36 (M)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Anosmia</td>
<td valign="top" align="center">4</td>
<td valign="top" align="left">Septum (left)</td>
<td valign="top" align="left">Mucocele</td>
<td valign="top" align="left">Endoscopic surgery</td>
<td valign="top" align="left">Cepha (4 days)</td>
<td valign="top" align="left">Penicillin (126 days)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">22</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Kamogashira, et al. [<xref ref-type="bibr" rid="b8-kjorl-hns-2022-00451">8</xref>]</td>
<td valign="top" align="center">39 (M)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Continuous exposure to dusty environment</td>
<td valign="top" align="left">Epistaxis, Rt cheek pain</td>
<td valign="top" align="center">2</td>
<td valign="top" align="left">Inferior meatus (right)</td>
<td valign="top" align="left">Foreign body with fungal infection</td>
<td valign="top" align="left">Endoscopic endonasal surgery</td>
<td valign="top" align="left">Penicillin G (7 days)</td>
<td valign="top" align="left">Amoxicillin (6 months)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">12</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Lee, et al. [<xref ref-type="bibr" rid="b9-kjorl-hns-2022-00451">9</xref>]</td>
<td valign="top" align="center">36 (M)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Anosmia</td>
<td valign="top" align="center">5</td>
<td valign="top" align="left">Septum (left)</td>
<td valign="top" align="left">Mucocele</td>
<td valign="top" align="left">Endoscopic endonasal surgery</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Amoxicillin (4 months)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">12</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Kim, et al. [<xref ref-type="bibr" rid="b10-kjorl-hns-2022-00451">10</xref>]</td>
<td valign="top" align="center">33 (F)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Nasal obstruction, intermittent epistaxis, purulent rhinorrhea, headache</td>
<td valign="top" align="center">12</td>
<td valign="top" align="left">Inferior turbinate and septum (right)</td>
<td valign="top" align="left">Rhinolith</td>
<td valign="top" align="left">Endoscopic endonasal surgery</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Cefdinir (?)</td>
<td valign="top" align="left">Mupirocin nasal irrigation (?)</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Kim, et al. [<xref ref-type="bibr" rid="b11-kjorl-hns-2022-00451">11</xref>]</td>
<td valign="top" align="center">17 (F)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Nasal obstruction, rhinorrhea</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">Septum (right)</td>
<td valign="top" align="left">Osteoma</td>
<td valign="top" align="left">Endoscopic endonasal surgery</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Penicillin (8 weeks)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">12</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Batzakakis, et al. [<xref ref-type="bibr" rid="b12-kjorl-hns-2022-00451">12</xref>]</td>
<td valign="top" align="center">34 (F)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Nasal obstruction, halitosis, unilateral offensive rhinorrhea, PND</td>
<td valign="top" align="center">12</td>
<td valign="top" align="left">Nasal cavity (left)</td>
<td valign="top" align="left">Foreign body or fungal infection</td>
<td valign="top" align="left">Endoscopic endonasal surgery</td>
<td valign="top" align="left">Penicillin G (3 days)</td>
<td valign="top" align="left">Penicillin (4 weeks)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">1.5</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Zalagh, et al. [<xref ref-type="bibr" rid="b13-kjorl-hns-2022-00451">13</xref>]</td>
<td valign="top" align="center">25 (M)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Nasal obstruction, purulent nasal discharge, episodic headache with epistaxis</td>
<td valign="top" align="center">?</td>
<td valign="top" align="left">Nasal cavity (right)</td>
<td valign="top" align="left">Rhinolith</td>
<td valign="top" align="left">Endoscopic removal (under local anesthesia)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Ciprofloxacin (6 weeks)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="center">?</td>
<td valign="top" align="left">x</td>
</tr>
<tr>
<td valign="top" align="left">Mun, et al.</td>
<td valign="top" align="center">7 (F)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Severe vomiting at few days prior</td>
<td valign="top" align="left">Nasal obstruction, purulent nasal discharge</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">Nasal cavity (left)</td>
<td valign="top" align="left">Foreign body</td>
<td valign="top" align="left">Endoscopic removal (under local anesthesia)</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">x</td>
<td valign="top" align="left">Mupirocin oint apply (1 week)</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">x</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>ca c, cancer with; HTN, hypertension; DM, diabetic mellitus; HIV, human immunodeficiency virus; R/o, rule-out; post-op, post operative; PND, post nasal drip</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>